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events (x2 = 25, p = 0.0001) and death (X2 = 21, p = 0.001); while the
presence of ischemia (X2= 11,p= 0.001) as the best predictor of soft events.
The 4 year hard event free survival was 90% in pts with large defects and
97% in Pts with no or small defects (p = 0.01). The 4 year freedom from
revaecularization was 78% in pts with ischemia and in pts with no ischemia
(p= 0.05).
Thus, the predictors of ham’andsoftevents are different in pts with stable
CAD. The perfusion defect size, a marker of LV function, is an important
predictor of death while ischemia is a more important predictor of other
events.
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D941 140 MyocardialProstsglandinReceptors(EP3Subtype)Inhibit the Inotropic Effect of
&Adrenergic Stimulation
T. Hohlfeld, K. Schr&. hrstitut ftir Phmrna/ro/ogie,
Heinrich-Heine-Univemit4 Dusseldorf, Germany
Proateglandin receptors (EP3 subtype) have recently been identified in the
human heart. The functional role of these receptors, however, is unknown.
In order to examine cardiac EP3 receptor function, prostaglandin (PG) EI
(1 nmol/min) wee infused into the IAD of anesthetised open-chest minipigs.
Heaft rate, systolic blood pressure and regional contractile activity (sonomi-
crometric crystals, area suppliedbytheLAD) were not changedatbaseline
conditions.In contrast, PGEI markedly decreased the inotropic effect of
3 @rein isoprenaline (iv.) by 74 * 18% (n = 5, p c 0.05 vs. control).
Following pretreatment with reserpine (50 r.@kg, iv., 8 h before surgery),
PGEi was equally effective (85+ 8Y0reduction of isoprenaline-stimulatad
contractility, n = 4, p <0.05 vs. control), suggesting a postsynaptic effect
of PGE1. The EP3 receptor-selectiveagonistM&B 28.787 (1 nmol/min, i.e.)
also decreased the inotropic action of isoprenaline by a similar extent, while
butaprost (5 nmollmin, i.e., selective for EP2receptors)did not.This indicates
that myocardial EP3 receptors mediate the obsewed negative inotropic ac-
tion of PGEI. The positive inotropic action of the phosphodiesteraae inhibitor
milrinone (0.2 mgikg, iv.), but not of ouabain (10 wdkg, iv.), was also inhib-
ited by PGE1, suggesting that myocardial EP3 receptors selectively reduce
cAMP-mediatad contractile effacfe. This was confirmed by in vitro exper-
iments, ahowing an inhibition of earcolemmal membrane cAMP formation
by PGEt (ECSO= 2.5 nM). It is concluded that myocardial EP3 receptors
inhibit cAMP-mediated inotropic effects. This provides a rational explanation
of the well-established antiischemic action of endogenous and exogenous
proeteglandins.
m941 141 PulmonaryArteryBandingUpregulateeVaacularEndotheliaiGrowth Factor and ita Flkl Receptor
in Pig Haarts
S. Kuki, E.P. Bauer, M. Arras, R. Zimmerman, W. Schapar.
Mex-Planck-institute, Bad Nauheim, Germany
Although vascular endothelial growth factor (VEGF) is a potent and specific
endothelial mitogen that is able to induce angiogenesis, little is known ra-
garding the role of VEGF in in vivo cardiac hypertrophy which requires a
propcmionai coronaty artety growth. We investigated the gene expression
of VEGF and its Flkl and Fltl receptors using right ventricular hypertrophy
(RVH) after pulmonary artwy banding (PAB) in pigs, which exhibit a coronary
artery anatomy and distribution similar to humans. 35 pigs (5 groups) were
used, each group included 4 bandad (B) and 3 eham (S)-pigs. Pigs were
killed at 2h, Id, 3d, 7d, and 24d after PAB. RV/(lVS + LV) in weight was usad
for index of RVH. VEGF, Flkl, Fltl and atrial natriuretic factor (ANF) mRNA
were analyzed by Northern blot hybridization. Mean trans-banding pressure
TimeafterPAB
2h Id 3d 7d 24d
RV/(lVS+LV) 1.07 1.0 1.31 1.65** 1.63**
ANF/18S 1.12 2.42** 5.24”* 1.63 1.14
VEGF/18S 2.03”” 1,57 1,11 0.95 1.06
Flkll18S 1.56” 2.53** 1.64*” 1.04 1.18
Values(mesn)forS sraexpreseedssfold-increseeoverS. *p <0.05, ** p <0.01 vsS.
gradient was 29 mmHg. Significant RVH wae observed within the first week
after PAB.The expreeeion of ANF in RV wae transiently obsemd during the
development of RVH, but not in the established RVH. The rapid induction of
VEGF and the following persistent expression of Flkl were obsewad prior
to progression of RVH. In addition, we investigated transmural distribution of
these mRNAs at 2h after PAB, however, there were no differences in mRNAa
level between subendo&ardiurn and subepicardiurr,r.The expression of FM
could not be observed, The extremely rapid expression of the Iigand and
receptor mRNA before hypertrophy suggeet functions of the VEGF-system
in addition to angiogenesis.
[941-1~ DeWeaeeCfLeVelsof lKAc~mRhlAinPatientsvvith
Chronic Atrial Fibrillation but no Changes in the
Sercoplaamic Reticulum Calcium ATPase and
Phospholamban
B.J. Brundel, I.C. Van Gelder, R.H, Henning, L.E. Deelman,
A.E. Tuinenburg, W.H. Van Gilst, H.J. Crijns. Dept. of Cardio/ogyand
Clinical Pharmacology, Thoraxcentec fJniveraify Hoapita/ Gronirrgan, The
Natherfands
Impairment of atrial and ventricular function is an important consequence of
atrial fibrillation (AF). This maybe caused by a tachycardiomyopathy (TCM).
Nodataonthe underlying mechanism are available. The aim of this atudyisto
investigate mRNA Ievela of proteins influencing the calcium and potassium
handling, sarcoplasmic reticulum calcium ATPase (SERCA), phospholam-
ban (Pi) and one WmpOflent Ofthe iKAch,the cardiac inward rectifier (CIR).
Right atrial appendages (RAA) wera obtained from 18 patients with AF and
from 19 controls in einus rhythm who were matched for age, sex, undetfy-
ing disease, drugs and functional class.Previous duration of AF was 9 *
3 months. Total RNA of RAA was isolated and reversely transcribed into
cDNA. In a single semi-quantitative polymerase chain reaction the mRNA of
interest and of glycereldehyde-3-phosphate dehydrogenaee (GAPDH) were
coamplified and eepareted by gel-electrophoresis. cDNAa of the ethidium
bromide stained gels were quantified by densitrometry. The CIR mRNAcon-
tent was significantly reduced (–38%, p c 0.05). SERCAand PI mRNA Ievele
were unchanged. GAPDH levels were identical for both groups. Conclusion:
chronic AF did not affect mRNA levels of SERCAand P1.However, the mRNA
level of one component of IKKW (CIR) was significantly downregulated in the
RAA of patients suffering from chronic AF.
/941-143/ lnVOlvementOfJanuSkina*S (Jak)in (Jrokinass
Receptor (uPAR) Signaling - A Novel Pathway to
Alter Gene Expression in the Development of
Atherosclerosis?
A. Weis, 1.Dumler, R. Diefz, D.C. Gulba. Humboldt l/niversityat Berlin,
Berlin, Germany
The binding of urokinase-type plaeminogen activator (uPA) to cell surfacea
via its specific receptor (uPAR) facilitates migration, invasion and matrix
degradation for vascular smooth muacle cells (SMCS) and endothelial cells
(ECe)- kay events in atherosclerosis and in intimal thickening after vascular
injuty. However, the exact signaling pathwaye of the uPA/uPAR syatem are
so far unknown. This etudy proposee a role for the Jak/STAT pathway in
the uPAR-mediated signaling by providing a cloee association of the Janus
kinases Jakl and Tyk2 with the uPAR in human aortic SMCS and human
umbilical vein ECe. Cell Iysates of a primary culture of SMCe and ECSwere
immunoprecipitatad with anti-uPAR monoclinal antibodies. Precipitated pro-
teins were separated by gel electrophoreeie, transferred to a PVDF mem-
brane, immunoblottad with polyclonal anti-Jakl, anti-Jak2, anti-Jak3, and
anti-Tyk2 antibodies, and viaualizad by chemi-luminescent etaining. There
wae a close association of uPAR with Jakl and Tyk2 in both SMCe and ECS
cell Iysatee,but not with Jak2 and Jak3.
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Weconclude.thatassemblageof uPAR,Jakl andTyk2in one receptor
complexindicatesthefunctionalcooperationof the uPARandtheJakfSTAT
pathwayasoneregulatorfor SMCandECmigrationandproliferation.
m941 144 Ecto-5’-nucleotidaeei PhosphorylstedvisProteinKinseeC intheCsninePreconditioned
Myocardium
H.Funaya,M.Kitakeze,K.Yoshida’,T.Kurfhare,M.Hori.TheFirstDept.
of Med.,OeekaUniw Osaka,Japan,1TheDept.ofLegalMed.,Yamaguchi
Univ., Yamaguchi,Japan
We havereportedthat cardioprotectionin ischemicpreconditioning(IP) is
attributableto activationof ecto-5’-nucbotidase(ecto-5’-NT),the enzyme
responsiblefor adenosineproductionin the caninemyoosrdiumand that
ecfo-5’-NTis activatedby proteinkinaseC (PKC).However,there is no
directevidencethat scto-5’-NTis the substratefor PKCinthe myocardium.
ReexaminedwhetherPKCphoaphotylatesecto-5’-NTofthecanineprecon-
ditionedmyooardium.Intheopenchestdogs,1Pwasproducedby4timesof
5 mincoronatyocclusionwitha 5-reininterval(n = 5). In anotherdogs,we
administeredPMA(0.5pmolJkg/min)intothecoronatyarteryfor4 timesof 5
minwitha 5-reininterval(n = 5). Fiveminafter1Pand PMAprocedure,we
sampledmyocardialtissuesand measuredactivityof acto-5’-NTand PKC
inthemembranefraction.Furthermore,weperformedthe immunoblotusing
SpSCifiCantibodiesof phosphotylationprotein(phosphothreonine,phoapho-
serineandphosphotyrosine)afierimmunoprecipitationof thesamesamples
byecto-5’-nucleotidaseantibody.Activitiesofecto-5’NT(71.3* 5.7and69.3
+ 4.7vs.42.3+ 3.8 nmol/mgproteitimin)andPKC(27.8+ 3.5and26.3+
4.2vs.6.2+ 0.9nmol/mgproteinlmin)increasedinthe 1PandPMAgroups,
comparedwiththe controlgroup,respectively.Weobservedthe threonine-
serinephosphorylationofecto-5’-NTintheIPandPMAgroups.A majorbsnd
weedetectedby phosphothreonineandphosphoaerineantilmdieain the IP
andPMAgroups,andwhichwasnotdetectedbyphosphotyrosinantibodyin
bothgroups.Weconcludethatecto-5’-NTof the myocardiumisphoaphoiy-
IatedandactivatedviaproteinkinaseC inthe ischemicpreconditioning.The
targetenzymethatcausescardioprotactionin isohemicpremnditioningmay
beecto-5’-NT.
m941 145 Endogenouainductionof PisaminogenActivstor.inhibitorin RsbbitsbyAngiotensinii sndits
Hexapeptide(3-6) Fragment
W.L.Daley,S. Plavin,D.E.Vaughan.BroddorvWestRoxburyVAMedical
CentecBrigham,USA,Women’sHospital,HarvardMedicalSchool,Boston,
MA,USA,VanderbiltUniversitySchoolof Medicine,Nashville,Tennessee,
USA
Plaeminogenactivatorinhibitor(PAI-1)playsan importantrolein regulating
thefibrinolyticsystem.PAI-1isthoughttobetheprinciplephysiologicinhibitor
of tissuetypeplasminogenactivator(t-PA).However,theregulationof PAI-1
isnotwellunderstood.Inthisstudy,we investigatedwhethertheinductionof
PAI-Ibythe renin-angiotensinsystem(RAS)wasseoondatyto Angiotensin
II (Angll)or its by-productthe hexapeptide(3-6) fragmentAngiotensinIV
(AnglV).IntwentyfournormalNewZealandWhiterabbits,Angll (n= 6)and
AnglV(n = 6) were infusedat gradedconcentration(2,4 and6 @kg/rein)
over160minutes.Meanlevelsof PAI-I activityincreasedsignificantlyin a
dosedependentmannerfrom (4 * 3.7 ng/mL)beforeAngll infusionto (26
+ 3.3 nglmL)at the end of Angll infusion(p < 0.00001)and from (1.1+
1.02ng/mL)beforeAnglVinfusionto (27 * 3.7 n@mL)at the endof AnglV
infusion(p = < 0.00001),whereasPAI-1activitydecreasedin the control
groupinfusedwithnormalsaline(n= 6), from(4.8* 1.5ng/mL)to (1 * 0.5
n@mL)(p= < 0.001).Theanimalsthatwerepretreatedwithamastetin(Angll
receptorblocker,n = 6) priorto receivinggradedinfusionof Angll,exhibitad
theexpectedrisein bloodpressurewhilethe PAI-Iactivityweesignificantly
reduced(6.7+ 2.1 ng/mL)in comparisonto the infusionof Angllalone(p =
< O.00001).
Conclusion:TheseIn vivodatastronglysuggestthatthe increaseinthe
circulatinglevelsof PAI-1inducedby the renin-angiotensinsystemmaybe
secondaryto bothAngll andAnglV.
m941 146 inVitroFibriiiinAaeambiyandBiosyntheticAbnormalitiesof Fibriiiininthe MarfanSyndrome
T.Brenn,U.Franke1,H.Furthmayr.Departmentof Patfro/ogyUniversity
Schoolof Medicine,Stanford,USA,1Departmentof Genetics,Howard
HughesMedicalInstitute,Stanford,USA
The Marfansyndromehas been linkedto the extracellularmatrixprotein
fibrillin-1(FBN1)whichaggregatesto forminsolublemicrofibrils.Mutations
in the FBNI gene resultin abnormalpatternsof synthesis,secretionand
matrixdepositionof FBN1in dermal fibroblasteas weli as reducedim-
munofiuorescentstainingof microfibrils.Groupaof patientswere identified
by a,quantitativepulsechasetechniquemeasuringFBNI, whichcorrelate
withseverityandprognosisof thedisease.Thepresentstudywasdeaigned
tobetferdefinethebiosynthesisandassemblyofFBN1usingthequantitative
pulsechasetechniquein combinationwith indirectimmunofluorescencein
vitro.Whennormalhumanfibroblastsweregrown(l%ulture),trypsinizedand
maintainedfor an additionalperiod(2Qculture),FBNI in the tissueculture
mediumcouldreadilybe separatedfrom an intracellularand extracellular
microfibrillarform.Whilethesynthesisof FBNIwasnotaffected,theamount
of insoluble,microfibrillarFBN1wasquitesensitiveto cultureconditionsin
the IQcultureas wellas the 2Qculture.Trypsinizationof labeledfibrobieets
underconditionsusedfor replatingof cellsshowedincompletedigestionof
insoluble,microfibrillarFBNI and FBN1wasalsodetectedby immunofluo-
reecenceinfragmentedandclumpymicrofibrilsonedayafterreplatingof the
trypsinizedcells,suggestingthat insoiublemicrofibriilarmaterialhad been
transferredtogetherwiththecells.Fourdaysofculturewererequiredfor the
formationof a normalmicrofibriilarnetworkand longerculturetimesdid not
changethestainingpattern.Thissuggeststhatpreformedmicrofibrflsaofas
‘nuclei’fortheincorporationofnewlyformedFBNI. IncertainMFSfibroblasts
a considerablereductionandanalteredpatternin microfibrillarorganization
is observed.Ourdata indicatethat the pulsechaseassaymeasuresa re-
ductionin FBN1depositionin suchfibroblasts,sincefewermicrofibrilsare
availablefor the depositionof a labeledFBNI moleculeduringthe chase
period.Alteredmicrofibrillarstructuresassembledin culturemayalsooon-
tfibute to the reductionin matrixdepositionof FBNI due to the dominant
negativeaffect,inspiteofa relativelyshortchaseperiod.
1941-1471 AMiaeen8eMutstionof theeNOSGenein
PatientewithCoronaryHeartDiseaseandits
Poasibieinteraction.withACEI/DGene
Polymorphismfor CoronaryRisk
K.Liu,H.Bai,K.Saku,T.Hiroki,K.Arakawa.FukuokeUniversitySchoo/of
Medicine,Fukuoka,Japan
In mronaryangiogrephicelly(CAG)proven-coronaryheartdisease(CHD)
patients,we identifieda missensemutationin exon 7 in the eNOSgene
by directDNAsequencing:a G to T transitionthat changedGlum (GAG)
to Asp (GAT).We screenedthis mutationin CAG proven-CHDpatients
(n = 432) and normalcontrols(n = 207). The variantdistributionof this
mutationwee16.7%in patienta,but only7.6%in controls.Thiadifference
wassignificant(,Yz= 9.413,p=0.002).Nosignificantdifferenceswerefound
amongpatientsubgroupswith I-vesael,2-veeeeland 3-veeselstenosis.
However,thefrequencyofvariantswiththismutationinpatients(n=46) with
restenosisafterpercutaneoustransluminalcoronaryangioplaety(PTCA)is
markedlyhigherthanthat in patients(n = 56)withoutrestenosia(27.1%vs
lp.s~o, ,y2 = 4.638,p = 0.031).MultipleIbgisticregressionanalysisrevealad
a significantassociationbetweenthe riskof CHDandthis eNOSmieaense
mutation(p = 0.032).To evaluatethe possibilityof an interactionbetween
this mutationandACEl/D polymorphismon the riskof CHD,we screened
theACEl/Dgenotypes.Invariantswiththismutation,theoddsratioforCHD
associatedwith the ACE DD genotypewas 4.71 (2.32+56, p = 0.039).
Amongpatientsdefinedas low-risk(serumapo B e 1.25@L,BMi <26
kg/m2,non-HT,non-DM,andnon-smoking),this interactionis evenstronger
[oddsratio:11.56(5.15-25.91,p = 0.010)].Cone/uaions:1. The frequency
of the GIu2W+Aspmissensemutationof the eNOSgenewasestablished
inJapanesecontrolsandCHDpatients;2. Thismutationmaybeassociated
withan increasedriskfor CHD;3. ThismutationmayinteractwithACEVD
polymo~hismsto affecttheriskforCHD.
1941-148] Adenovirai-MediatedGeneTherapyinducea
SuatsinadintrapericardiaiVaacuiarEndotheiiai
GrowthFactorExpreaaionin Dogs:Effecton
MyocsrdiaiAngiogeneeis
D.F.Lezarous,M.Shou,J.A.Stiber,V.Thirumurti,E.Hedge,E.F.Unger.
NHLBI,Bethesda,MD,USA
Weexaminedtheeffectsof intrapericerdialdeliveryof a replication-deficient
adenoviruscarryingthecDNAforvascularendotheliaigrowthfactor(AdCMV.
VEGFls5)onmyccerdialangiogenesisinanestablisheddogcoiiateralmwlel.
Ameroidconstrictorswereplacedon the proximalleft ciroumfiexcoronary
arteryofdogs.Tendayslater,6 x 109pfuAdCMV.VEGF(n=5), AdRSV.@
(n = 4), or saline(n =7) weredeliveredthroughan indwellingpericerdial
catheter.Transfaotionefficiencywashigh,withextensive~gslstaininginthe
epi- and pericardium.Perfoardialand aerumVEGFlevelswere measured
byELISAin6 dogs(averagevaluesshown).Collateralperfusion,essessed
withrediolabeledmicroapheres26dayspoet-Rx,weesimilarin all groups.
